Final Report of Phase II Study of Sorafenib, Cytarabine, and Idarubicin for Initial Therapy in Younger Patients with Acute Myeloid Leukemia

Gardado en:
Detalles Bibliográficos
Main Authors: Ravandi, Farhad, Yi, Cecilia Arana, Cortes, Jorge E., Levis, Mark, Faderl, Stefan, Garcia-Manero, Guillermo, Jabbour, Elias, Konopleva, Marina, O'Brien, Susan, Estrov, Zeev, Borthakur, Gautam, Thomas, Deborah, Pierce, Sherry, Brandt, Mark, Pratz, Keith, Luthra, Rajyalakshmi, Andreeff, Michael, Kantarjian, Hagop
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091714/
https://ncbi.nlm.nih.gov/pubmed/24487412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.54
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares